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The second British Stomach Cancer Group trial was a randomised controle trial of
adjuvant radiotherapy or cytotoxic mothepy after gastretomy for a It recruited between
1981 and 1986. No srival advantage has b n onstrated for the patients r vuivmg cither type of adjuvant
therapy compared with those Udeoing surgery alone. We report on 436 patients randomised into the trial
tgether with 203 tients, who did not fulfil the trial criteria, referd to the trial. A unvariate (log-rank)
analysis ofpatholgcal factors obtained fiom the local ref centres showed that tumour siz,
type, number of sites invoved, depth of invasion, involvement of resction lnes and lymph nodes and
histological grade were significant deteminants of suival. Histological revew by two his-
topathologists found that the Lauren clssification and histogical grade, but not the Ming dassification, were
significant prognostic factors. The degree oflymphocytic and eosinophilic infiltration and presenc ofdysplaia
assessd by one of the pathologists showed a signifiant correlation with survival. However, inter-observer
correlation for these hological parameters and grade was poor. Multivariate analysis identifid only depth of
invasion, resction line and nodal involvment as significant dpendent pathological variables infling
survivaL This study confirms the need for expert of the resected mn to obtain the important
information on depth of invasion and nodal status and also reveal some variation histological t,
particulaly grading in gastri carcioma.
A qwrdc gastric cancer, pathology; histological dassification; multivariate analysis; prognosis
Gastric carcinoma remains a major cause of death within the
United Kingdom and, despite the advances in surgical prac-
tice, there has been no change in survival over the past 25
years. To try to influence outcome in this diseaw, the British
Stomach Cancer Group has run two trials of adjuvant
therapy. The first trial, which recruited from 1976 to 1981,
showed no benefit from adjuvant 5-fluorouracil and
mitomycin C (Allum et al., 1989a). The second trial, which
recruited from 1981 to 1986, compared adjuvant
chemotherapy using 5-fluorouracil, doxorubicin (Adriamycin)
and mitomycin C, or radiotherapy, with surgery alone (Hal-
lisey et al., 1994). In the second trial, various pathological
findings were recorded in detail. Histopathologists reporting
adenocarcinomas are familiar with grading into three
categories: well, moderately and poorly differentiated. How-
ever, alternative classifiation systems are used in some cen-
tres. The Lauren classification divides gastric carcinoma into
the intesnal and diffuse types (Lauren, 1965). The Ming
classification is based on the growth pattern of the tumour it
divides gastric carcinomas into an expanding type and an
infiltrative type (Ming, 1977). These grading systems and
other pathological parameters have not previously been
analysed formally in such a large cohort of patients with
detailed follow-up data within the United Kingdom.
Patent and
The organisation of the trial and its results have been de-
scribed in detail previously (Allum et al., 1989b; Hallisey et
al., 1994), but these are summarised briefly here. The trial
recruited patients aged 15-74 who had a resection for stage
II-IVA(i) adenocarcinoma of the stomach from ten centres
in the United Kingdom. The staging was undertaken using a
trial-specific clinicopathological staging system formulated in
1980 (Table 1), and randomisation was based on the surgical
and histological assessment of the referring centre. In addi-
tion, 123 patients ineligible on criteria other than stage, 68
patiets with stage I disease and 12 patients with metastatic
disease were also followed up in accordance with the tral
protocol. Data were collated and analysis undertaken at the
Cancer Research Campaign Trials Unit in Birmingham.
Trial patients were randomised between the three treat-
ment groups: surgery alone, surgery and chemotherapy or
surgery plus radiotherapy. There has been no effect of either
adjuvant treatment on survival. WVherever possible patients
TableI Clinicopathological stagingsystemofgastricadenocarcinoma
used in the trial
Stage Parameters
I Mucosa +ve
Submucosa +ve or -ve
Muscularis propria +ve or -ve
Serim8 -ve
Nodes -ve
H Mucosa +ve
Submucosa +ve
Muscularis propria +ve
Serosa + ve
Nodes - ve
In Mucosa +ve
Submucosa +ve or -ve
Muscularis propria +ve or -ve
Sos' +ve or - ve
Nodes +ve
IVA Resected
(j)b LOcal residual dises
(ij)b Metastatic residual disease
WVB Unresected
"Serosa' as used here means either subserosal fat involvement or
involvement of the serosal surface.
bMostly only determined clnically, some verfied histologically.
Correspondence: DA Levison, Department of Pathology, Ninewells
Hospital & Medical School, Dundee DDI 9SY, UK
Received 24 June 1994; revised 5 January 1995; accepted 5 January
1995were seen at regular intervals. Complete follow-up is
available to death or 5 years in all but one trial patient, who
emigrated at 4.8 years, and in 93% of the non-trial patients.
Notification of death was primarily from the referring
cinician or the patient's general practitioner with additional
information being supplied by the West Midlands and
Thames Cancer Registries.
Pathologists from each of the participating centres pro-
vided extensive histopathological data including tumour size,
macroscopic type, number of sites involved, depth of pene-
tration (extent), resection line and lymph node involvement
and histological grade. An independent pathology review
panel verified the microscopic data. In addition, two
experienced histopathologists (DL,MD) independently
assess the tumours using the Lauren and Ming
classifications, as well as a conventional grading system based
on the degree of differentiation. They also determined the
extent of infiltration by inflammatory cells (lymphocytes and
eosinophils) by a semiquantitative grading system (using a
three-point scale corresponding to light, moderate and heavy
infiltrates agreed between the assessors) and recorded the
presence of associated intestinal metaplasia and dysplasia.
Sb
A-
I
Tlhe statistical analyses were performed using the 'BMDP'
Biomedical Data Package Statistical Software (Dixon et al.,
1990). The correlation between observers was assessed using
the kappa statistic. The duration of survivaL the primary
end point, was calculated from the date of operation to the
date ofdeath or the censor date of 31 January 1991, when all
patients had been on follow-up for 5 years. Initial assesment
of the factors was made using the method of Kaplan and
Meier (1958) and the signcnce of the differences eamined
using the log-rank x test (Peto et al., 1977).
The Cox model (Cox, 1972) has been used to identify
variables having an independent effect when controlling for
the correlations inherent in the data. The optimum scale of
nt for each variable was chosen from the survival
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distributions. The Cox model was used to assess the
pathology vaables alone, the results ofthe additional assess-
ments alone and both combined. The criterion for inclusion
of a variable was P<0.05 and for exclusion P>0.05.
Analysis was undertaken using all variables and repeated
with a restricted set of variables, seklcted on the basis of the
univariate and the prior multivariate analyses. As the Cox
model only uses cases with complete data, the restricted set
of variables increases the number of cases included in the
final model. The adjusted hazard ratios, together with their
95% confidence intervals, were calcuated using the regres-
sion coefficient from the final model.
Reslts
From the initial group of 639 patients, survival data are
missing for 18 non-trial patients, leaving 621 patients
available for analysis. The median duration of survival was
15 months (95% confidence interval 14-17 months). At the
time of analysis, 113 patients were alive, with 447 of the 508
deaths being due to recurrent cancer. There was no
significnt survival difference between the trial groups
(x2= 3.87, degrees of freedom = 2, P=0.14). In two cases
where the local pathologists diagnosed anapatc carcinoma,
the review pathologists' diagnosis was of lymphoma. One of
these patients developed liver involvement 3 years after
surgery and had a complete response to chemotherapy.
Univariate analysis
The results of the univanate analysis for the initial
pathological assesments and the factors measured in the
pathology review are smarisd in Tables H and III. All of
the pathological factors measured at the local centres were
shown to be sin tly related to survival. Nodal involve-
ment, extent (depth of invasion) and resection line involve-
ment were the most significant factors, followed by tumour
size, number of sites involved, macroscopic type and his-
tology. The pathology review identified additional factors
TableI Univariatelog-rank survivalanalyss (n = 621)forinitialpathologicalfactorsassessed
at klo centres
Median survival in months
Factor Codes Nmnber (95% CI) j P-vahw
Tumour size (cm) <2 62 38(14, 65) 42.7 <0.0001
2-4 157 23(16,29)
4-6 135 12(10, 16)
6-8 97 16(11, 22)
>8 111 10 (8, 13)
Macroscopic type Superficial 26 62(36, 89) 32.8 <0.0001
Papillary 27 22(11,37)
Ulkerated 398 14(12, 17)
Scirrhous 75 16(11, 21)
Diffuse 61 9 (7,11)
Mucoid 3 Not reached
Other 19 20(12,31)
No of sites 1 363 17 (14, 20) 40.1 <0.0001
2 142 17(14, 27)
3 36 11 (8,13)
>,4 63 9 (6,13)
Histology Well 35 34(15,61) 14.4 0.006
Moderate 202 18 (13, 23)
Poor 256 13 (11, 16)
Signet ring 75 16 (10,22)
Anaplastic 32 10 (5, 15)
Extent Mucosa 43 82(57, 106) 65.8 <0.0001
(depth ofinvasion) Muscle 61 58(29, 86)
To serosa 516 12(11, 14)
Lines of resection Clear 485 18(16, 21) 48.6 <0.0001
Involved 104 8 (7, 10)
Lymph node No 157 55(38, 68) 75.4 <0.0001
involvement Yes 429 11(10, 13)P-ihul*gcI -1I-- I Wh acb mgm cu.sinp
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Table m Univariate log-rank survival analysis (n = 445) for extra pathology information
assessed at reviw by two pathologists (DL and MD)
Median survival in months
Factors Codes Nwnbers (95% CI) XI P-value
Lauren, DL Intestinal 246 51 (5, 92) 14.7 0.0007
Diffuse 116 16 (9, 25)
Mixed 34 12(10, 15)
Lauren, MD Intestinal 232 20(14, 33) 11.2 0.004
Diffuse 106 15(12, 19)
Mixed 31 10 (8, 14)
Histological Well 23 29(14, 37) 18.5 0.0001
grade, DL Moderate 223 17(14,21)
Poor 174 9 (8, 12)
Histological Well 69 21 (13, 30) 13.9 0.001
grade, MD Moderate 1-53 16 (12,21)
Poor 180 11 (8, 14)
Ming, DL Not done
Ming, MD Expanding 174 15(12, 18) 0.06 0.97
Infiltrative 182 14(10, 15)
Mixed 38 12 (7, 21)
Lymphocytic + + + (heavy) 5 19(15, 23) 2.2 0.3
infiltrate, DL + + (moderate) 63 9 (8, 12)
+(mild) 188 10 (6, 15)
Lymphocytic + + + 58 18 (15, 23) 9.1 0.0
infiltrate, MD + + 202 9 (8, 14)
+ 144 10 (5, 16)
Eosinophilic + + + 7 59 (8, 84) 4.1 0.13
infiltrate, DL + + 46 14 (8, 28)
+ 203 13(11, 14)
Eosinophilic + + + 70 20(12, 28) 10.1 0.006
infiltrate, MD + + 102 19(13, 29)
+ 232 12 (9, 14)
Intestinal Present 164 15 (12, 21) 2.6 0.1
metaplasia, DL Absent 71 12 (8, 14)
Intestinal Present 276 16(14, 20) 3.4 0.07
metaplasia, MD Absent 98 12 (9, 14)
Dysplasia, DL Present 109 18(14, 27) 11.1 0.0009
Absent 117 12 (8, 14)
Dysplasia, MD Present 106 28(19, 38) 14.1 0.0002
Absent 262 12(10, 14)
which are significantly associated with survival, including
histological grade and presence of dysplasia or intestinal
metaplasia. The Ming classification was a poor indicator of
survival. The lymphocytic and eosinophilic infiltrates were
both found to be associated with survival when measured by
one pathologist (MD), but not the other (DL).
Inter-observer variation was assessed between the two
pathologists (DL,MD) as shown in Table IV. Good correla-
tion was obtained for the Lauren classification (K= 0.84),
with acceptable correlation on the assessment of intestinal
metaplasia (x = 0.61) and histological grade (x = 0.59). How-
ever, the reproductibility of the results for the assessment of
lymphocytic and eosinophilic infiltrates and dysplasia was
poor.
Multivariate analysis
The results of the Cox multiple regression analyses are sum-
marised in Table V. When only the initial pathological fac-
tors were used, nodal involvement, resection line involve-
ment, depth of invasion and histology were all significantly
related to survival, confirming the findings of the log-rank
analysis. No other factors entered the model. Repeating this
analysis including only these four factors did not alter the
coefficients. The relative risks ranged from 1.62 to 2.66, the
greatest risk being associated with the depth of invasion
when tumour spread to the serosa is compared with disease
confined to the mucosa.
Considering the additional pathological factors, only dys-
plasia and lymphocytic infiltration measured by MD and
Table IV Inter-observer variation between the two pathologists (DL
and MD)
Percentage ofcases
Factor disagreeing Kappa
Lauren 11.7 0.84
Histological grade 24.7 0.59
Lymphocytic infiltrate 52.0 0.16
Eosinophilic infiltrate 34.3 0.26
Intestinal metaplasia 15.6 0.61
Dysplaia 31.0 0.39
histological grade measured by DL were significant. How-
ever, when considering all variables together, once nodal
involvement, resection line involvement and depth of
invasion entered the model, the variables assessed in the
pathology review provided no independent information.
This analysis of a large group of patients from a prospective
study with carefully documented follow-up has confirmed the
prognostic value of conventional pathological factors in
predicting outcome following surgery for gastric adenocar-
cinoma. The factors which had important independent
signi in multivariate analysis of pathology variables
obtained at the local centres were lymph node and resection
line involvement, depth of invasion and histological grade.Cp e
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Table V Summary of the Cox stepwise multiple regression analysis
Regression Relative riska
Factor coefficient (P) X' to remove P-value (95% CI)
(a) Pathologicalfactors assessed by local centres (n = 515)
Extent 0.49 22.4 <0.0001 2.66 (1.67-4.17)
Nodal involvement 0.73 37.4 <0.0001 2.07 (1.61-2.67)
Resection lines 0.62 22.4 <0.0001 1.86 (1.45-2.40)
Histology 0.12 4.5 0.03 1.62 (1.02-2.52)
(b) Additionalpathologicalfactors assessed at review (n = 322)
Lymphocytic 0.29 9.26 0.002 1.79 (1.21-2.59)
infiltration, MD
Histological grade, DL 0.26 5.46 0.01 1.68 (1.07-2.63)
Dysplasia, MD 0.46 11.1 0.0009 1.591(1.1902.12)
(c) Combination offactors at local centre and review (n = 445)
Extent 0.49 19.9 <0.0001 2.66(1.64<4.41)
Resection lines 0.68 22.6 <0.0001 1.97 (1.51-2.58)
Nodal involvement 0.67 28.1 <0.0001 1.94(1.49<2.54)
aTberisk ratios arecaklulated from the formulaexp(P,where k isthe difference between the
high-risk andlow-risk groups. Ineach case, the extreme groups arecompared, e.g., forhistology,
lowrisk,well;highnsk,anaplastic.Thegroupingsused areidentical tothegroupingsshowninthe
umvanate analysis.
The independent significance of all of these factors, except
histological grade, was still evident even in the smaller
numbers of centrally reviewed cases available for analysis
(Table V). This loss of significance of grade in the reviewed
cases is not surprising as even in the larger number of locally
assessed cases it was not great (P = 0.03).
In the univariate analysis a large number of variables were
identified which had a significant effect on survival but which
were not found to be independent predictors in the Cox
model. This effect is likely to be due to the cormlation
between these factors and those identified in the Cox model.
The size of the primary correlates with the number of sites
involved, and both correlate with the extent and the presence
of lymph node invasion.
The degree of inflammation in the tumour has previously
been reported as being related to survival (Davessar et al.,
1990). In the present study, attempts to quantify the degree
of lymphocytic and eosinophilic infiltration have been shown
to lack reproducibility. Agreement between observers was
only seen in 48% for lymphocytic infiltration and 66% for
eosinophilic infiltration. One of the pathologists (MD)
assessed the infiltrate on large numbers of cases con-
secutively, while the other (DL) assessed the cases as the
slides were received at the review centre. It is likely that this
accounts for some of the variation in assessment and limits
the value of these factors even though the assessment by one
pathologist (MD) did have some correlation with outcome.
There was also disagreement in the diagnosis of tumour-
associated dysplasia in 31% of cases; this is not surprising in
view of the well-recognised difficulty ofdiagnosing dysplasia.
The presence of dysplasia as assessed by one pathologist
(MD) was correlated with improved survival. It is difficult to
account for this effect, but it may result from the association
between dysplasia and intestinal type tumours. It is also
difficult to account for the relatively low x-coefficient (0.61,
though this is acceptable) between MD and DL in the recor-
ding of associated intestinal metaplasia. This is usually
regarded as relatively easy to assess, but may reflect different
thresholds for labelling minor changes such as the presence
of occasional goblet cells as metaplasia (DL having a higher
threshold). The different numbers asessed by the two
pathologists (DL = 235, MD = 375) reflet simply the stage
in the trial at which DL began to include some parameters as
part of the overall assessment, while MD assessed all
parameters in all cases, and the pathologists worked entirely
separately in different hospitals.
Although the Lauren clssfication was found to have prog-
nostic value on univariate analysis, it lost its power in the
Cox model. This concurs with the results of a large
Norwegian prospective multicentre trial (Haugstvedt et al.,
1993). Lauren reflects the degree of differentiation by
dividing tumours into two main grades. There is evidence
that intestinal type tumours have a different natural history
to diffuse carcinomas, being predisposed to by environmental
factors and having an association with precancerous lesions
such as intestinal metaplasia and superimposed dysplasia. In
diffuse carcinomas, genetic factors are thought to play an
important role as they appear to arise independent of intes-
tinal metaplasia (Elster et al., 1979), possibly from dysplastic
foveolar epithelium (Grundmann and Schlake, 1979). Some
studies have supported the usefulness and reproducibility of
the Lauren classification, but there are problems with this
system. The classification results in a significant number of
cases which have a mixed intestinal and diffuse pattern or
those which are unclassifiable. These cases accounted for
approximately one-fifth of gastnc carcinomas assessed in one
series of resection specimens (Caygill et al., 1983), the figure
being approximately 14% in Lauren's original series (Lauren,
1965) and 13% in the current series.
T1he Ming classification is based on the predominant
tumour type and ideally requires examination of the whole
specimen. Although previous studies have supported its prog-
nostic significance (Ribeiro et al., 1981; Davessar et al.,
1990), it is less widely used than Lauren. Attempts to com-
bine the Lauren and Ming classifications have failed to im-
prove on their individual prognostic value (Ribeiro et al.,
1981). In our own series, the Ming classification was made on
the available samples of the specimen and the assessment has
limitations. The Ming classification was not found to be a
significant predictor of survival.
The results suggest that conventional histological grading
provides the most valuable additional information though,
again, this is a subjective assessment and dependent on the
individual pathologist. One of the pathologists in the review
panel (DL) showed a high threshold for classifying tumours
as well differentiated and placed fewer cases in this category
than the other pathologist (MD). This reluctance was
associated with a better separation of the survival curves by
grade.
The Cox model confirms the results of previous
population-based (Stout 1959) and hospital-based studies
(Soreide et al., 1982; Bozzetti et al., 1986; Maruyama, 1987;
Elias et al., 1988; Baba et al., 1989; Arveux et al., 1992)
which have demonstrated the importance of lymph node
involvement and depth of invasion within the gastric wall as
predictors of survival. Okusa et al. (1990) found that the
survival rate after curative gastrectomy for carcinoma
significantly decreased as the number and the proportion of
involved lymph nodes increased. The prognostic value of
resection line involvement was demonstrated in both BritishPx6aogca r p ws&Cbdcom111psheC
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Stomach Cancer Group trials (Hallisey et al., 1993; British
Stomach Cancer Group, 1984) and other studies (Nakamura
et al., 1992). The assessment at the local centres provided all
the pathological information of independent prognostic
value, confirming the results of Akoh et al. (1991), who also
found that survival correlated with depth of invasion but not
histological grading. This has important practical implica-
tions for histopathologists and emphasises the importance of
careful attention to specimen preparation in order to
optimise detection of lymph node metastases and resection
line involvement and selection of blocks to determine the
maximum depth of invasion. We consider it optimal to
receive gastrectomy specimens fresh and unfixed immediately
after removal, so that they can be opened, examined and
pinned out flat on a cork board, then fixed overnight. Then
blocks are taken.
There is currently much discussion about the difficulty of
assessing dysplasia, but the application of histological
grading has generally not been considered to be a major
problem. There appears to be scope for improving the re-
producibility of standard histological grading in gastric car-
cinoma. Each pathologist used his/her own criteria in this
study, which is the current situation in routine practice, but
the results of the study suggest that there is a need for
standardisation. Perhaps another study could be done on this
material using standardised criteria to see if the prognostic
signifi of grading alters. However, the histology of gas-
tnc carcinoma shows arbitrary variation in different parts of
a tumour (Stout, 1959; Ackerman and del Regato, 1962), and
this heterogeneity should therefore be considered a factor
which may also be of importance. The introduction of new
approaches to chemotherapy, including neoadjuvant therapy,
makes it particularly important to have good base- line his-
topathological data to assess the impact of the new regimens.
In conclusion, this study of pathological prognostic factors
in a large series of patients with resected gastric carcinoma
has confirmed the value of commonly reported factors in
multivariate analysis, particularly lymph node and resection
line involvement and depth of tumour invasion. A con-
siderable amount of prognostic information is obtainable
from the simultaneous application of these factors in a
suitable staging system. Although new techniques are being
investigated as possible predictors of survival, they need to be
compared with these established parameters and proven to
have independent prognostic value in multivariate analysis
before being added to the list for routine pathological assess-
ment of gastric carcinoma.
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